Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.2 USD | -0.93% | +0.81% | -5.41% |
Apr. 24 | Transcript : BioMarin Pharmaceutical Inc., Q1 2024 Earnings Call, Apr 24, 2024 | |
Apr. 24 | BioMarin Pharmaceutical Q1 Non-GAAP EPS, Revenue Increase -- Shares Down After Hours | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.41% | 17.31B | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.94% | 29.36B | |
+56.40% | 24.49B | |
-44.23% | 11.26B | |
-17.60% | 11.62B | |
-13.96% | 11.31B | |
+6.67% | 8.31B | |
+2.09% | 7.63B |
- Stock Market
- Equities
- BMRN Stock
- News BioMarin Pharmaceutical Inc.
- BioMarin Pharmaceutical's Hemophilia A Biologics License Application Resubmission Accepted by FDA